- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Veterinary Medicines Regulations 2013, PART 7.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
45. The Secretary of State, when issuing a marketing authorisation, must approve all containers, packaging, labels and package leaflets.
46. A label and package leaflet of an authorised veterinary medicinal product may contain in legible characters the words “UK authorised veterinary medicinal product” or, if the marketing authorisation provides, other wording specified in the authorisation indicating that the product is authorised in the United Kingdom.
Extent Information
E1This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only
46. A label and package leaflet of an authorised veterinary medicinal product may contain in legible characters the words “[F4UK(NI)] authorised veterinary medicinal product” or, if the marketing authorisation provides, other wording specified in the authorisation indicating that the product is authorised in [F5Northern Ireland].
Extent Information
E3This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only
Textual Amendments
F4Word in Sch. 1 para. 46 substituted (N.I.) (31.12.2020) by The Animals (Health, Identification, Trade and Veterinary Medicines) (Amendment) (EU Exit) Regulations (Northern Ireland) 2020 (S.R. 2020/353), regs. 1(3), 10(13)(i)(i)
F5Words in Sch. 1 para. 46 substituted (N.I.) (31.12.2020) by The Animals (Health, Identification, Trade and Veterinary Medicines) (Amendment) (EU Exit) Regulations (Northern Ireland) 2020 (S.R. 2020/353), regs. 1(3), 10(13)(i)(ii)
47.—(1) All labels and package leaflets must be in English, but may contain other languages provided that the information given is identical in all the languages.
(2) This requirement does not apply in the case of a product imported by a veterinary surgeon and administered by or under the responsibility of that same veterinary surgeon.
48.—(1) If it is reasonably practicable to do so, the following must be provided on the immediate packaging, in legible characters—
(a)the name, strength and pharmaceutical form of the veterinary medicinal product;
(b)the name and strength of each active substance, and of any excipient if this is required under paragraph 2 of the summary of product characteristics;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and, if appropriate, “To be supplied only on veterinary prescription”;
(g)the contents by weight, volume or number of dose units;
(h)the marketing authorisation number;
(i)the name and address of the marketing authorisation holder [F3, the local representative designated under paragraph 18 of this Schedule] or, if there is a distributor authorised in the marketing authorisation, that distributor;
(j)a suitably labelled space to record discard date (if relevant);
(k)the target species;
(l)the distribution category;
(m)the words “Keep out of reach of children”;
(n)storage instructions;
(o)the in-use shelf-life (if appropriate);
(p)for food-producing species, the withdrawal period for each species or animal product concerned;
(q)any warning specified in the marketing authorisation;
(r)disposal advice;
(s)full indications;
(t)dosage instructions;
(u)contra-indications;
(v)further information required in the marketing authorisation;
(w)if the product is one that requires a dose to be specified for the animal being treated, a space for this.
(2) If all this is on the immediate packaging, there is no need for any outer packaging or a package leaflet.
Extent Information
E2This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only
Textual Amendments
F3Words in Sch. 1 para. 48(1)(i) inserted (E.W.S.) (31.12.2020) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(b), 4(7)(b)
48.—(1) If it is reasonably practicable to do so, the following must be provided on the immediate packaging, in legible characters—
(a)the name, strength and pharmaceutical form of the veterinary medicinal product;
(b)the name and strength of each active substance, and of any excipient if this is required under paragraph 2 of the summary of product characteristics;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and, if appropriate, “To be supplied only on veterinary prescription”;
(g)the contents by weight, volume or number of dose units;
(h)the marketing authorisation number;
(i)the name and address of the marketing authorisation holder or, if there is a distributor authorised in the marketing authorisation, that distributor;
(j)a suitably labelled space to record discard date (if relevant);
(k)the target species;
(l)the distribution category;
(m)the words “Keep out of reach of children”;
(n)storage instructions;
(o)the in-use shelf-life (if appropriate);
(p)for food-producing species, the withdrawal period for each species or animal product concerned;
(q)any warning specified in the marketing authorisation;
(r)disposal advice;
(s)full indications;
(t)dosage instructions;
(u)contra-indications;
(v)further information required in the marketing authorisation;
(w)if the product is one that requires a dose to be specified for the animal being treated, a space for this.
(2) If all this is on the immediate packaging, there is no need for any outer packaging or a package leaflet.
Extent Information
E4This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only
49.—(1) If it is not reasonably practicable to have all the required information on the immediate packaging then this paragraph applies.
(2) The immediate packaging must have at least the following information—
(a)the name of the veterinary medicinal product, including its strength and pharmaceutical form;
(b)the name and proportion of each active substance, and of any excipient if knowledge of the excipient is needed for safety reasons;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and if appropriate, “To be supplied only on veterinary prescription”;
(g)the words “Keep the container in the outer carton”.
(3) In addition, the immediate packaging must have as much of the required information as is reasonably practicable.
(4) The outer packaging must contain all the required information if it is reasonably practicable to do this, and if it is not reasonably practicable to do this a package leaflet must be supplied with the product in accordance with the following paragraph.
50.—(1) If it is not reasonably practicable to have all the required information on the immediate packaging or all of this information on the outer packaging, there must be a package leaflet supplied with the product, containing all the required information except for the batch number and the expiry date, and including the name of both the marketing authorisation holder and, if different, the name of the distributor named in the marketing authorisation.
(2) If there is a package leaflet, the immediate packaging and the outer packaging must both refer the user to it.
(3) A package leaflet must relate solely to the veterinary medicinal product with which it is included.
(4) It must be written in plain English.
(5) Only a package leaflet approved in the marketing authorisation may be included with the veterinary medicinal product.
51.—(1) In the case of ampoules or other unit dose forms, where the container cannot bear legibly the required information, only the following information must be shown on the immediate packaging—
(a)the name of the veterinary medicinal product;
(b)the name and strength of the active ingredient;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and if appropriate, “To be supplied only on veterinary prescription”.
(2) The outer packaging must contain all the required information if it is reasonably practicable to do this, and if it is not reasonably practicable to do this a package leaflet must be supplied with the product, except that the ampoule need not refer to the package leaflet.
52. As regards small immediate packaging containing a single dose, other than ampoules, on which it is impossible to give the required information, all the required information must appear on the outer packaging or outer packaging and package leaflet, but the immediate packaging must be labelled with the batch number and the expiry date and, if there is room, the other information in the preceding paragraph.
53.—(1) A homeopathic remedy registered under these Regulations must be labelled in accordance with this paragraph.
(2) There must be no specific therapeutic indication on the labelling or in any information relating to it.
(3) The labelling (or labelling and package leaflet) must contain the following and no other information—
(a)the words “homeopathic remedy without approved therapeutic indications for veterinary use”;
(b)the scientific name of the stock or stocks followed by the degree of dilution, using the symbols of the pharmacopoeia used (if the homeopathic remedy is composed of more than one stock, the labelling may mention an invented name in addition to the scientific names of the stocks);
(c)the name and address of the registration holder and (on the package leaflet) of the manufacturer;
(d)the method and, if necessary, route of administration;
(e)the expiry date;
(f)the pharmaceutical form;
(g)the contents of the pack;
(h)any special storage precautions;
(i)the target species;
(j)any necessary special warnings;
(k)the batch number; and
(l)the registration number.
54. The Secretary of State may permit variations in the above in any individual marketing authorisation if this is necessary for public or animal health purposes or the protection of the environment.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: